February 13, 2012 05:08 ET

Market Research: Anti-Infective Sales Grow to $53 Billion Despite Generic Threat

ROCKVILLE, MD--(Marketwire - Feb 13, 2012) - has announced the addition of the new report "World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)," to their collection of Pharmaceuticals market reports. For more information, visit

The world anti-infective market includes products from three primary segments:

  • Antifungals
  • Antibacterials
  • Antivirals

Each of these segments has unique circumstances for growth and is analyzed in detail in the following chapters. However, there are also some common trends which affect all markets such as generic competition, price issues, and reimbursement issues. Currently both the antifungal and antibacterial segments have experienced heavy generic competition, limiting growth despite the new products to each market segment. Concerns in the antibacterial segment over resistance have resulted in additional funding for new treatments specifically targeting resistant bacteria. Although there seems to be a solution on the surface, many developers are reluctant to follow this development path. Some of these reasons are discussed in the study.

Worldwide, anti-infectives combined are worth more than $53 billion in 2011. The report includes statistical information for infections by type worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers.

For more information, visit

About is the leading provider of global market intelligence products and services. With over 300,000 research reports from more than 700 top consulting and advisory firms, offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. For more information, call Veronica Franco at 240-747-3016 or visit

Contact Information

  • Contact:
    Veronica Franco
    Email Contact